Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Pharmacopeia enters research collaboration with Pharmacia & Upjohn

Jan. 21, 1999

AxyS and RPR enter second collaborative agreement

Jan. 21, 1999

PDL issues further licenses under its antibody humanization patents

Jan. 20, 1999

Idun obtains rights to technology with application to HIV and other diseases

Jan. 20, 1999

New neurological and immunological therapies basis of Neurocrine Biosciences-Caliper collaboration

Jan. 19, 1999

LeukoSite, Warner-Lambert collaborate on integrin antagonist research

Jan. 19, 1999

Targeted Genetics, Sangamo combine two novel technologies for drug discovery

Jan. 19, 1999

Palatin and Nihon Medi-Physics intend to develop radiopharmaceutical products

Jan. 18, 1999

Tenth HuMAb-Mouse licensing agreement for Medarex: Immunex granted broad rights

Jan. 18, 1999

Milestone reached by Cadus in drug discovery collaboration with SmithKline Beecham

Jan. 18, 1999

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...